1. Ginsenosides in central nervous system diseases: Pharmacological actions, mechanisms, and therapeutics
   Jing Lu et al, 2022, Phytotherapy Research CrossRef
2. Rg1 exhibits neuroprotective effects by inhibiting the endoplasmic reticulum stress-mediated c-Jun N-terminal protein kinase apoptotic pathway in a rat model of Alzheimer's disease
   JUN-SHAN MU et al, 2015, Molecular Medicine Reports CrossRef
3. F1FOATP Synthase Is Expressed at the Surface of Embryonic Rat Heart-Derived H9c2 Cells and Is Affected by Cardiac-Like Differentiation
   Marina Comelli et al, 2016, Journal of Cellular Biochemistry CrossRef
4. Cooperation of Rel family members in regulating Aβ1-40-mediated pro-inflammatory cytokine secretion by retinal pigment epithelial cells
   Junran Sun et al, 2017, Cell Death & Disease CrossRef
5. Cucurbit[7]uril Macrocyclic Sensors for Optical Fingerprinting: Predicting Protein Structural Changes to Identifying Disease-Specific Amyloid Assemblies
   Nilanjana Das Saha et al, 2022, Journal of the American Chemical Society CrossRef
6. Molecular drug targets and therapies for Alzheimer’s disease
   Dev Singh et al, 2014, Translational Neuroscience CrossRef
7. Improving Alzheimer's disease by altering gut microbiota in tree shrews with ginsenoside Rg1
   Limei Wang et al, 2020, FEMS Microbiology Letters CrossRef
8. Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls
   Srinivas Ayyadevara et al, 2016, Aging Cell CrossRef
9. Systematic review of plasma-membrane ecto-ATP synthase: A new player in health and disease
   Federica Taurino et al, 2018, Experimental and Molecular Pathology CrossRef
10. Unveiling OSCP as the potential therapeutic target for mitochondrial dysfunction-related diseases
    Mingyue Zhang et al, 2024, Life Sciences CrossRef